The Pharmacy Technician Certification Board surveyed 74 certified pharmacy technicians in August about which drug shortages are affecting their work. Sixty-two percent of the respondents work in health systems, 14 percent in community pharmacies and 24 percent in other settings.
Pharmacy techs pointed to shortages of drugs for cancer, attention-deficit/hyperactivity disorder, weight loss and diabetes — such as Mounjaro, Ozempic and Wegovy — and local anesthetics.
The six most pressing supply issues among pharmacy technicians:
1. Adderall, an ADHD drug.
2. Bupivacaine, a local anesthetic.
3. Carboplatin, a drug that treats cancer of the lung, bladder, breast, head and neck, cervix, ovaries, testicles, uterus, kidney, brain and eyes.
4. Cisplatin, a chemotherapy for bladder, ovarian, testicular, head and neck, lung, cervix, esophagus and brain cancer. It is also used for malignant pleural mesothelioma, a cancer in the lining of the chest or abdomen, and neuroblastoma, a cancer that begins in nerve cells.
5. Fluorouracil/5FU, a medication for colon cancer, rectal cancer, breast cancer, pancreas and stomach cancer, cervix and esophagus cancer, head and neck cancer, ovarian cancer and renal cell cancer.
6. Lidocaine, a local anesthetic.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
